Lyka Labs Q1FY27 profit jumps 159%, revenue up 45% YoY

Key takeaway from the June 2026 quarter

Lyka Labs reported a strong improvement in profitability in Q1FY27 for the quarter ended June 30, 2026, supported by faster growth in exports than domestic business. Standalone net profit was reported to have risen 159% year-on-year to ₹2.1001 crore (₹210.01 lakh). On a consolidated basis, net profit was reported at ₹2.0466 crore (₹204.66 lakh), up 105.44% year-on-year. Revenue momentum was also firm, with standalone revenue from operations rising 45.01% year-on-year to ₹42.3094 crore (₹4,230.94 lakh). Despite the strong top-line growth, the company also saw profitability pressures at the operating level, with standalone EBITDA margin contracting to 11.84%.

How exports led the growth mix

A key driver highlighted in the quarter was exports. Export revenues surged 68.03% year-on-year to ₹14.8342 crore (₹1,483.42 lakh), which outpaced domestic growth of 15.91%. The export-led mix matters because it can change the company’s revenue profile and near-term cost structure. Higher export volumes can lift revenue quickly, but they can also come with different operating costs and financing needs. In Lyka Labs’ case, the quarter still ended with a notably higher profit base than the same period last year. The export growth figure is the clearest operational detail provided alongside the quarterly results.

Revenue from operations: standalone vs consolidated

Lyka Labs reported standalone revenue from operations of ₹42.3094 crore in Q1FY27 versus ₹29.1764 crore in Q1FY26, reflecting 45.01% year-on-year growth. On a consolidated basis, revenue from operations was reported at ₹42.3094 crore in Q1FY27, up 28.11% from ₹33.0254 crore in Q1FY26. The matching standalone and consolidated Q1FY27 revenue number, as presented in the data, is an important detail for readers tracking the company’s reporting. It also indicates that the disclosed quarter’s topline comparison is being made on the “revenue from operations” line.

EBITDA growth, but margin compression

EBITDA increased year-on-year, but margins moved the other way. Standalone EBITDA was ₹5.0112 crore in Q1FY27 versus ₹4.1306 crore in Q1FY26, a rise of 21.32%. Consolidated EBITDA was ₹4.9657 crore in Q1FY27 versus ₹4.3173 crore in Q1FY26, up 15.02%. Even with EBITDA growth, the company’s standalone EBITDA margin was stated to have contracted to 11.84%. The contraction was attributed to higher finance costs and lower other income, as cited in the provided text.

Profit after tax: two sets of figures in the data

The provided information contains two different profit figures for the same quarter. In the narrative, Lyka Labs’ standalone net profit is stated as ₹2.1001 crore (₹210.01 lakh), while the financial table lists “Net Profit After Tax” at ₹1.9933 crore (₹199.33 lakh) for standalone Q1FY27. Similarly, consolidated net profit is stated as ₹2.0466 crore (₹204.66 lakh) in the narrative, while the table lists consolidated Q1FY27 PAT at ₹1.9480 crore (₹194.80 lakh). Since both sets appear in the data, they are presented as reported without adjustment.

EPS data points for Q1FY27

The table provided also includes basic EPS. Standalone EPS (basic) for Q1FY27 was ₹0.58 compared with ₹0.33 in Q1FY26, a growth of 75.76%. Consolidated EPS (basic) for Q1FY27 was ₹0.57 versus ₹0.39 in Q1FY26, showing 46.15% growth. Separately, another market snapshot in the text notes “Lyka Labs Ltd EPS (TTM) is -2.81,” and also cites EPS of -2.13 for a “latest quarter,” alongside sales of ₹24.411 crore (₹244.11 million) and net income of -₹7.607 crore (₹76.07 million). These EPS and profitability metrics indicate that the company’s trailing and other-period performance metrics shown in the dataset differ from the Q1FY27 snapshot.

Historical context from recent quarterly data

The text also includes a quarterly results table in crores for Mar 2025 to Mar 2026, showing volatility in operating performance. For Mar 2026, net sales were ₹28.03 crore and operating profit was -₹4.48 crore, with exceptional items of -₹23.01 crore. Profit after tax for Mar 2026 in that table was -₹29.77 crore, compared with ₹0.28 crore in Dec 2025 and -₹3.63 crore in Sep 2025. This backdrop helps explain why a sharp year-on-year turnaround in Q1FY27 profit stands out in the reported numbers.

Market snapshots mentioned alongside results

Multiple price snapshots are present in the dataset. One line shows “66.74” with “-1.36 (-2.00%)” under “Currency in INR,” and another states “Lyka Labs CMP Rs.69.” Elsewhere, the “current share price” is cited as ₹71.2, and another snapshot shows “74.33 +0.75 (+1.02%).” Since these appear as separate data points without timestamps in the excerpt, they are best read as different market snapshots rather than a single continuous move.

Financial summary table (normalized to ₹ crore)

Why the quarter matters for investors tracking Lyka Labs

Q1FY27 combines three signals that investors typically track together: a sharp profit rebound, faster export growth than domestic, and margin pressure despite higher EBITDA. The export number is particularly prominent, with export revenues at ₹14.8342 crore and growth of 68.03%. At the same time, the mention of higher finance costs and lower other income alongside EBITDA margin compression to 11.84% indicates that the cost and income mix remains an important variable. The quarter ended June 30, 2026, and the reported numbers provide a fresh reference point against the volatility seen in prior quarters shown in the dataset.

Conclusion

Lyka Labs’ Q1FY27 results for the quarter ended June 30, 2026, showed strong year-on-year improvement in profitability and revenue, led by a sharp jump in export revenues. The same data also flags operating margin pressure, with the standalone EBITDA margin stated at 11.84% due to higher finance costs and lower other income. Investors will likely watch whether export momentum sustains and whether margin pressures ease in subsequent quarters, as future results are reported in the regular quarterly earnings cycle.